Proteomic analysis of the cerebrospinal fluid of patients with schizophrenia

Amino Acids

Volumn 25, Issue 1, 2003, Pages 49-57

  Jiang, L ^a,b,c   Lindpaintner, K ^c   Li, H F ^d   Gu, N F ^d   Langen, H ^c   He, Lin ^a,b   Fountoulakis, Michael ^c  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Chinese Academy of Sciences   (China)

^c F HOFFMANN LA ROCHE LTD   (Switzerland)

^d SHANGHAI MENTAL HEALTH CENTER   (China)

Author keywords

Apolipoprotein A IV; Central nervous system; Cerebrospinal fluid; Proteomics; Schizophrenia

Indexed keywords

APOLIPOPROTEIN A4; COMPLEMENT COMPONENT C3; FIBRINOGEN; GENE PRODUCT; HAPTOGLOBIN; PLASMA PROTEIN; VITAMIN D BINDING PROTEIN;

ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; HUMAN; MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; SCHIZOPHRENIA; TECHNOLOGY; TWO DIMENSIONAL GEL ELECTROPHORESIS; UNINDEXED SEQUENCE;

EID: 0043270502     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00726-003-0356-6     Document Type: Article

References (38)

1. Andersson M, Alvarez-Cermeno J, Bernardi G, Cogato I, Fredman P, Frederiksen J, Fredrikson S, Gallo P, Grimaldi LM, Gronning M (1994) Cerebrospinal fluid in the diagnosis of multiple sclerosis:a consensus report. J Neurol Neurosurg Psych 57: 897-902
2. Andreasen N, Minthon L, Clarberg A, Davidsson P, Gottfries J, Vanmechelen E, Vanderstichele H, Winblad B, Blennow K (1999) Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample. Neurology 53: 1488-1494
3. Berndt P, Hobohm U, Langen H (1999) Reliable automatic protein identification from matrix-assisted laser desorption/ionization mass spectrometric peptide fingerpints. Electrophoresis 20: 3521-3526
4. Boyles JK, Notterpek LM, Anderson LJ (1990) Accumulation of apolipoproteins in the regenerating and remyelinating mammalian peripheral nerve. J Biol Chem 265: 17805-17815
5. Brackenridge CJ, Jones IH (1972) Group-specific component and haptoglobin distributions in schizophrenic states. Clin Genet 3: 325-333
6. Csaszar A, Kalman J, Szalai C, Janka Z, Romics L (1997) Association of the apolipoprotein A-IV codon 360 mutation in patients with Alzheimer's disease. Neurosci Lett 230: 150-154
7. Davidsson P, Paulson L, Hesse C, Blennow K, Nilsson CL (2001) Proteome studies of human cerebrospinal fluid and brain tissue using a preparative two-dimensional electrophoresis approach prior to mass spectrometry. Proteomics 1: 444-452
8. Engidawork E, Lubec G (2001) Protein expression in Down syndrome brain. Amino Acids 21: 331-361
9. Fountoulakis M, Gasser R (2003) Proteomic analysis of the cell envelope fraction of Escherichia coli. Amino Acids 24: 19-41
10. Fountoulakis M, Juranville J-F, Röder D, Evers S, Berndt P, Langen H (1998) Reference map of the low-molecular-mass proteins of Haemophilus influenzae. Electrophoresis 19: 1819-1827
11. Fountoulakis M (2001) Proteomics: current technologies and applications in neurological disorders and toxicology. Amino Acids 21: 363-381
12. Fountoulakis M, Juranville J-F, Dierssen M, Lubec G (2002) Proteomic analysis of the fetal brain. Proteomics 2: 1547-1576
13. Fujimoto K, Fukagawa K, Sakata T, Tso P (1993) Suppression of food intake by apolipoprotein A-IV is mediated through the central nervous system in rats. J Clin Invest 91: 1830-1833
14. Fukagawa K, Knight D, Hamilton KA, Tso P (1995) Immunoreactivity for apolipoprotein A-IV in tanycytes and astrocytes of rat brain. Neurosci Lett 199: 17-20
15. Goldman D, Merril CR, Ebert MH (1980) Two-dimensional gel electrophoresis of cerebrospinal fluid proteins. Clin Chem 26: 1317-1322
16. Goodrum JF, Bouldin TW, Zhang HZ, Maeda N, Popko B (1995) Nerve regeneration and cholesterol reutilization occur in the absence of apolipoproteins E and A-I in mice. J Neurochem 64: 408-416
17. Greber S, Lubec G, Cairns N, Fountoulakis M (1999) Decreased synaptosomal associated protein 25 levels in the brain of patients with Down syndrome and Alzheimer's disease. Electrophoresis 20: 928-934
18. Harrington MG, Merril CR, Fuller Torrey E (1985) Differences in cerebrospinal fluid proteins between patients with schizophrenia and normal persons. Clin Chem 31/5: 722-726
19. Harrington MG, Merril CR (1988) Cerebrospinal fluid protein analysis in diseases of the nervous system. J Chromatography 429: 345-358
20. Johnson G, Brane D, Block W, Kammen DP, Gurklis J, Peters JL, Wyatt RJ, Kirch DG, Ghanbari HA, Merril CR (1992) Cerebrospinal fluid protein variations in common to Alzheimer's disease and schizophrenia. Appl Theor Electrophor 3: 47-53
21. Langen H, Roeder D, Juranville J-F, Fountoulakis M (1997) Effect of the protein application mode and the acrylamide concentration on the resolution of protein spots separated by two-dimensional gel electrophoresis. Electrophoresis 18: 2085-2090
22. Maes M, Bosmans E, Genis G, Jong RD, Smith RS, Meltzer HY (1997a) In vivo immunomodulatory effects of clozapine in schizophrenia. Schizophr Res 26: 221-225
23. Maes M, Delange J, Ranjan R, Meltzer HY, Desnyder R, Cooremans W, Scharpe S (1997b) Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs. Psychiatry Res 66: 1-11
24. Maes M, Delanghe J, Chiavetto LB, Bignotti S, Tura GB, Pioli R, Zanardini R, Altamura CA (2001) Haptoglobin polymorphism and schizophrenia: Genetic variation on chromosome 16. 104: 1-9
25. Merched A, Xia Y, Papadopoulou A, Siest G, Visvikis S (1998) Apolipoprotein AIV codon 360 mutation increases with human aging and is not associated with Alzheimer's disease. Neurosci Lett 242: 117-119
26. O'Donovan MC, Owen MJ (1999) Candidate-gene association studies of schizophrenia. Am J Hum Genet 65: 587-592
27. Raymackers J, Daniels A, Brabandere VD, Missiaen C, Dauwe M, Verhaert P, Vanmechelen E, Meheus L (2000) Identification of two-dimensionally separated human cerebrospinal fluid proteins by N-terminal sequencing , matrix-assisted laser desorption/ionization-mass spectrometry, nanoliquid chromatography-electrospray ionization-time of flight-mass spectrometry, and tandem mass spectrometry. Electrophoresis 21: 2266-2283
28. Rohlff C (2001) Proteomics in neuropsychiatric disorders. Int J Neuropsychopharmacol 4/1: 93-102
29. Rudduck C, Franzen Goran, Hansson A, Rorsman B (1985a) Gc serum groups in schizophrenia. Hum Hered 35: 11-14
30. Rudduck C, Franzen G, Frohlander N, Lindstrom L (1985b) Gaptoglobin and transferrin types in schizophrenia. Hum Hered 35: 65-68
31. Sichmann A, Dormeyer W, Wortelkamp S, Woitalla D, Kuhn W, Meyer HE (2000) Identification of proteins from human cerebrospinal fluid, separated by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis 21: 2721-2728
32. Steinmetz A, Utermann G (1985) Activation of lecithin:cholesterol acyltransferase by human apolipoprotein A-IV. J Biol Chem 260/ 4: 2258-2264
33. Steinmetz A, Barbaras R, Ghalim N, Clavey V, Fruchart JC, Ailhaud G (1990) Human apoliporpotein A-IV binds to apolipoprotein A-I/A-II receptor sites and promotes cholesterol efflux from adipose cells. J Biol Chem 265/14: 7859-7864
34. Thaker G, Carpenter JR WT (2001) Advances in schizophrenia. Nature Medicine 7/6: 667-671
35. Weinberger DR (1995) From neuropathology to neurodevelopment. Lancet 346: 552-57
36. Wong CT, Tsoi WF, Saha N (1996) Acute phase proteins in male Chinese schizophrenic patients in Singapore. Schizophr Res 22: 165-171
37. Yuan X, Russell T, Wood G, Desiderio DM (2002) Analysis of the human lumbar cerebrospinal fluid proteome. Electrophoresis 23: 1185-1196
38. Yun M, Wu W, Hood L, Harrington M (1992) Human cerebrospinal fluid protein database: Edition 1992. Electrophoresis 13: 1002-1013